The 7th International Conference on Neuroscience, Neurology and Psychiatry Universitas Sumatera Utara

Introduction

The COVID-19 pandemic, also known as the coronavirus pandemic, is an ongoing global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Virus was first identified in December 2019 in Wuhan, China. The World Health Organization declared a Public Health Emergency of international concern regarding COVID-19 on January 30, 2020, and later declared it a pandemic on March 11, 2020. As of April 16, 2021, more than 138 million cases have been confirmed, with more than 2.98 million deaths attributed to COVID-19, making it one of the deadliest pandemics in history.

Recommended precautions include keeping your distance, wearing a face mask in public places, ventilating and filtering the air, washing your hands, covering your mouth when sneezing or coughing, disinfecting surfaces, and monitoring and isolating yourself from exposed or symptomatic people. Several vaccines have been developed and widely distributed since December 2020. Current treatments focus on managing symptoms, but work is underway to develop therapeutic drugs that can inhibit the virus. Authorities around the world have responded by imposing travel restrictions, lockdowns / quarantines, workplace hazard controls, and business closures. Many places have also been working to increase testing capacity and track contacts of infected people.

Neuroscience is an emerging branch of science that develops rapidly. It needs neurology, psychiatry, and psychology for us to understand it better. The aim of this conference is to educate and learn the current trends and research in neuroscience education. The 5^th International Conference on Neuroscience, Neurology and Psychiatry (ICoNaP) 2022 is a conference held by The Faculty of Medicine of Universitas Sumatera Utara for psychiatrists, neurologists, general practitioners, and other interested specialists; the theme for this year is “Exploring the Neuroscientific Impact of Covid-19”.

ICoNAP has been held annually since 2018. The conference invites both national and international speakers from many countries. Throughout these years the committee has invoted various speakers from Malaysia, Singapore, Germany, Australia, India, Thailand, the USA, France, and Malaysia. This year, we invite both national and international speakers from the United Kingdom, Japan, Australia, Singapore, and Malaysia and will be held as a virtual conference.

The conference serves as an opportunity for researchers and experts in neuroscience, neurology, and psychiatry to share their ideas, experiences, and insights. Articles and case reports will get a chance to be published in international journals. To this date, 920 researchers and experts have participated in previous ICoNAP. Additionally, more than 100 articles and case reports have been published.

This year the paper carries these various topics:

Empowering health resources after the pandemic

Recovering after the pandemic with better mental health

Cognition in neurology

Cytokine mechanism of schizophrenia, neurovascular disease and Covid-19

Genes in mental disorders

Sleep disturbance during the pandemic

Memory and Epilepsy

Other health-related topics

The Faculty of Medicine Universitas Sumatera Utara decided to hold the 5th ICoNaP international conference on 04-05 August 2022 for psychiatric specialists, neurologists, general practitioners, graduate and post-graduate students, and other interested specialists.

Organizing Institution

Universitas Sumatera Utara

Jl. dr. T. Mansur No. 9 Medan 20155, Indonesia

Committee

• Chair : Prof. Dr. dr. Elmeida Effendy, M.Ked., Sp.KJ(K) (Indonesia)
• Co-Chair : dr. Inke Nadia Diniyanti Lubis, M.Ked.(Ped), Sp.A, Ph.D (Indonesia)
• Secretary : Dr. dr. Aida Fitri, Sp.S(K) (Indonesia)
• Treasurer : Dr. dr. Mustafa M. Amin, M.Ked., M.Sc., Sp.KJ(K) (Indonesia)
• Program Chair : dr. M. Surya Husada, M.Ked., Sp.KJ (Indonesia)
• Liaison Chair : Dr. dr. Cut Aria Arina, Sp.S(K) (Indonesia)

Honorary Board

• Dr. Muryanto Amin, S.Sos., M.Si (Indonesia)
• Prof. Dr. dr. Aldy Safruddin Rambe, Sp.S (K) (Indonesia)

Editorial Board

• Prof. Mirko Spiroski, M.D., Ph.D (Ss. Cyril and Methodius University Skopje Macedonia)
• Prof. Banthit Chetsawang (Mahidol Universiry, Thailand)
• Prof. Uttam Kumar Sharma (Uttarakhand Ayurveda University, Haridwar Uttarakhand, India)
• Zoe Bichler, Ph.D (The Jackson Laboratory, USA)
• Prof. Dr. dr. Dina Keumala Sari, M.Gizi, Sp.GK (Universitas Sumatera Utara, Indonesia)
• Prof. Dr. dr. Elmeida Effendy, Sp.KJ (K) (Universitas Sumatera Utara, Indonesia)
• Prof. Dr. dr. Kiking Ritarwan, MKT., Sp.S.(K) (Universitas Sumatera Utara, Indonesia)
• Dr. dr. Mustafa M. Amin, M.Sc, M.Ked, Sp.KJ (K) (Universitas Sumatera Utara, Indonesia)

Reviewer Board:

• Prof. Sibylle Schwab, Ph.D. (University of Wollongong, Australia)
• Prof. Anurekha Jain, Ph.D (Jayoti Vidyapeeth Women’s University, India/B.R. Nahata College of Pharmacy, Mandsaur, India)
• Prof. Roger Ho Chun Man (National University of Singapore, Singapore)
• Prof. Mohamed Hatta Shaharom, M.D. (Cyberjaya University College of Medical Sciences 2005-2012/ Universiti Islam, Malaysia)
• Dr. Nerdy, S.Farm., M.Si., Apt (Institut Kesehatan Deli Husada, Deli Tua, Indonesia)

Editorial Policies

Peer Review Process

The articles submitted to the 5^th ICoNaP USU will be processed through a formatting review by the editor and a substantial review by independent reviewers. The reviewing process is conducted by the double blind review. The reviewers are chosen by an editor. The decision regarding article publication is based on the review result.

Editor applies a plagiarism scanning with Turnitin and Google Scholar before the article is subjected to a substantial review process.

Ethics

Authors:

1. Authors must ensure that they have written original works.
2. Authors must ensure that the manuscript has not been issued elsewhere.
3. Authors are responsible for language editing before submitting the article.
4. Authors submitting their works to the journal for publication as original articles confirm that the submitted works represent their authors’ contributions and have not been copied or plagiarized in whole or in part from other works without clearly citing.
5. Authors must notify any conflicts of interest.
6. Authors must report any errors they discover in their manuscript.
7. Any work or words of other authors, contributors, or sources should be appropriately credited and referenced.
8. An author agrees to the license agreement before submitting the article.
9. All articles must be submitted using online submission procedure.

Editorial Board:

1. Editorial Board must ensure a fair peer-review of the submitted articles for publication.
2. Editorial Board must disclose any conflicts of interest.
3. Editorial Board must ensure that all the information related to the submitted manuscripts is kept as confidential before publishing.
4. Editorial Board must evaluate manuscripts only for their intellectual content.
5. Editor-in-Chief will coordinate the work of the editors.

Reviewers:

1. Reviewers evaluate manuscripts based on content without regard to ethnic origin, gender, sexual orientation, citizenship, religious belief or political philosophy of the authors.
2. Reviewers must ensure that all the information related to submitted manuscripts is kept as confidential and must report to the Editor-in-Chief if they are aware of copyright infringement and plagiarism on the author’s side.
3. Reviewers must evaluate the submitted works objectively as well as present clearly their opinions on the works in a clear way in the review form.
4. Reviewers must keep information pertaining to the manuscript confidential.
5. A reviewer who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the Editor-in-Chief and excuse himself from the review process.

Timeline

Abstract and full paper : 04 August 2022

Reviewing Process : 08 August - 30 September 2022

Publication : November - December 2022

Call for papers

• Empowering health resources after the pandemic
• Recovering after the pandemic with better mental health
• Cognition in neurology
• Cytokine mechanism of schizophrenia, neurovascular disease and Covid-19
• Genes in mental disorders
• Sleep disturbance during the pandemic
• Memory and Epilepsy
• Other health-related topics